SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-20-002977
Filing Date
2020-02-13
Accepted
2020-02-12 17:47:48
Documents
3
Period of Report
2020-02-12
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8K nc10008465x2_8k.htm 8-K 14204
2 EXHIBIT 99.1 nc10008465x2_ex99-1.htm EX-99.1 4427
3 nc10008645x2_ex99-1logo.jpg GRAPHIC 138301
  Complete submission text file 0001140361-20-002977.txt   210341
Mailing Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121
Business Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121 858-752-6170
Cidara Therapeutics, Inc. (Filer) CIK: 0001610618 (see all company filings)

IRS No.: 461537286 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36912 | Film No.: 20605796
SIC: 2836 Biological Products, (No Diagnostic Substances)